Dual disruption of aldehyde dehydrogenases 1 and 3 promotes functional changes in the glutathione redox system and enhances chemosensitivity in nonsmall cell lung cancer
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dual disruption of aldehyde dehydrogenases 1 and 3 promotes functional changes in the glutathione redox system and enhances chemosensitivity in nonsmall cell lung cancer
Authors
Keywords
-
Journal
ONCOGENE
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-02-04
DOI
10.1038/s41388-020-1184-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Aldehyde Dehydrogenases: Not Just Markers, but Functional Regulators of Stem Cells
- (2019) Giuseppe Vassalli Stem Cells International
- Identification of cancer-type specific expression patterns for active aldehyde dehydrogenase (ALDH) isoforms in ALDEFLUOR assay
- (2018) Lei Zhou et al. CELL BIOLOGY AND TOXICOLOGY
- The role of cellular reactive oxygen species in cancer chemotherapy
- (2018) Haotian Yang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- 4-Hydroxynonenal (HNE) modified proteins in metabolic diseases
- (2017) José Pedro Castro et al. FREE RADICAL BIOLOGY AND MEDICINE
- ALDH1A3 is epigenetically regulated during melanocyte transformation and is a target for melanoma treatment
- (2017) M Pérez-Alea et al. ONCOGENE
- Aldehyde dehydrogenase 1A1 in stem cells and cancer
- (2016) Hiroyuki Tomita et al. Oncotarget
- N,N-diethylaminobenzaldehyde (DEAB) as a substrate and mechanism-based inhibitor for human ALDH isoenzymes
- (2015) Cynthia A. Morgan et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Aldehyde dehydrogenase as a marker and functional mediator of metastasis in solid tumors
- (2015) Mauricio Rodriguez-Torres et al. CLINICAL & EXPERIMENTAL METASTASIS
- ALDH1 Expression and the Prognosis of Lung Cancer: A Systematic Review and Meta-Analysis
- (2015) Dong Wei et al. Heart Lung and Circulation
- A STAT3-NFkB/DDIT3/CEBPβ axis modulates ALDH1A3 expression in chemoresistant cell subpopulations
- (2015) Claudia Canino et al. Oncotarget
- Mechanism of Cisplatin-Induced Cytotoxicity Is Correlated to Impaired Metabolism Due to Mitochondrial ROS Generation
- (2015) Yong-Min Choi et al. PLoS One
- Essential Role of Aldehyde Dehydrogenase 1A3 for the Maintenance of Non-Small Cell Lung Cancer Stem Cells Is Associated with the STAT3 Pathway
- (2014) C. Shao et al. CLINICAL CANCER RESEARCH
- Aldehyde dehydrogenases in cancer: an opportunity for biomarker and drug development?
- (2014) Klaus Pors et al. DRUG DISCOVERY TODAY
- Lipid Peroxidation: Production, Metabolism, and Signaling Mechanisms of Malondialdehyde and 4-Hydroxy-2-Nonenal
- (2014) Antonio Ayala et al. Oxidative Medicine and Cellular Longevity
- Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer
- (2013) Balázs Győrffy et al. PLoS One
- Cisplatin Induces a Mitochondrial-ROS Response That Contributes to Cytotoxicity Depending on Mitochondrial Redox Status and Bioenergetic Functions
- (2013) Rossella Marullo et al. PLoS One
- The prognostic significance of aldehyde dehydrogenase 1A1 (ALDH1A1) and CD133 expression in early stage non-small cell lung cancer
- (2013) Muhammad Alamgeer et al. THORAX
- Aldehyde dehydrogenases: From eye crystallins to metabolic disease and cancer stem cells
- (2012) Vasilis Vasiliou et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Aldehyde dehydrogenases in cellular responses to oxidative/electrophilicstress
- (2012) Surendra Singh et al. FREE RADICAL BIOLOGY AND MEDICINE
- Aldehyde Dehydrogenase 1A1 Possesses Stem-Like Properties and Predicts Lung Cancer Patient Outcome
- (2012) Xiao Li et al. Journal of Thoracic Oncology
- Prognostic impact of cancer stem cell-related markers in non-small cell lung cancer patients treated with induction chemoradiotherapy
- (2012) Kazuhiko Shien et al. LUNG CANCER
- NCBI GEO: archive for functional genomics data sets—update
- (2012) Tanya Barrett et al. NUCLEIC ACIDS RESEARCH
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- Aldehyde dehydrogenase: Its role as a cancer stem cell marker comes down to the specific isoform
- (2011) Paola Marcato et al. CELL CYCLE
- Targeting Malignancies with Disulfiram (Antabuse): Multidrug Resistance, Angiogenesis, and Proteasome
- (2011) B. Cvek CURRENT CANCER DRUG TARGETS
- The Human Protein Atlas as a proteomic resource for biomarker discovery
- (2011) F. Pontén et al. JOURNAL OF INTERNAL MEDICINE
- Bioluminescent Orthotopic Mouse Models of Human Localized Non-Small Cell Lung Cancer: Feasibility and Identification of Circulating Tumour Cells
- (2011) Pierre Mordant et al. PLoS One
- Aldehyde Dehydrogenase Activity Selects for Lung Adenocarcinoma Stem Cells Dependent on Notch Signaling
- (2010) J. P. Sullivan et al. CANCER RESEARCH
- Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
- (2010) T.-C. Chou CANCER RESEARCH
- Finding cancer stem cells: are aldehyde dehydrogenases fit for purpose?
- (2010) Malcolm R Alison et al. JOURNAL OF PATHOLOGY
- Lung cancer stem cells: tools and targets to fight lung cancer
- (2010) A Eramo et al. ONCOGENE
- The Role of Human Aldehyde Dehydrogenase in Normal and Cancer Stem Cells
- (2010) Irene Ma et al. Stem Cell Reviews and Reports
- Apoptosis and glutathione: beyond an antioxidant
- (2009) R Franco et al. CELL DEATH AND DIFFERENTIATION
- Aldehyde Dehydrogenase 1 Is a Tumor Stem Cell-Associated Marker in Lung Cancer
- (2009) F. Jiang et al. MOLECULAR CANCER RESEARCH
- Aldehyde dehydrogenase 1a1 is dispensable for stem cell function in the mouse hematopoietic and nervous systems
- (2008) B. P. Levi et al. BLOOD
- Non-P450 aldehyde oxidizing enzymes: the aldehyde dehydrogenase superfamily
- (2008) Satori A Marchitti et al. Expert Opinion on Drug Metabolism & Toxicology
- ALDH1A1 and ALDH3A1 expression in lung cancers: Correlation with histologic type and potential precursors
- (2007) Miten Patel et al. LUNG CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now